INTRODUCTION
Morbidity and mortality due to diarrheoa continues to be a major problem in many developing countries, including India and Bangladesh, especially amongst children. Infections due to a variety of bacterial etiologic agents, such as pathogenic Escherichia coli, Vibrio cholerae, Areomonas spp., Shigella spp., Salmonella spp., Pseudomonas spp., Klebsiella spp., Campylobacter spp., and Staphylococcus aureus are most common. However, antibiotic resistance is a major clinical problem in treating infections caused by these microorganisms. Many readily available plants in India are used in traditional folklore medicine for the treatment of gastrointestinal disorders such as cholera, diarrhea and dysentery [1] [2] [3] [4] [5] [6] [7] . However, several of them have not been investigated from a pharmacological point of view to demonstrate their antibacterial properties, which could support their use as anticholera or antidiarrheal remedies in traditional medicine. The objective of the present study was to evaluate the antibacterial activities of the extracts of some plants used in Indian traditional healthcare system, against a group of pathogenic bacteria. These plants are used by the indigenous people in different parts of India for the treatment of infectious diseases such as cholera, diarrhea, dysentery and other gastrointestinal disorders.
EXPERIMENTAL Plant materials
We co-trimoxazole (Co) (25 µg); ciprofloxacin (Cf)(5 µg); furazolidone (Fz) (100 µg); gentamicin (G)(10 µg); neomycin (N) (30 µg); nalidixic acid (Na) (30 µg); norfloxacin (Nx) (10 µg); streptomycin (S) (10 µg); tetracycline (T) (30 µg).
Preparation of extracts
Plant extracts were prepared by macerating the air-dried plant part (500 g) with 2500 ml of methanol in a Soxhlet apparatus for 18 h 9 .
The extract was then filtered through Whatman no. 42 filter paper and concentra- 
Antimicrobial assessment
Isolates were considered susceptible, less susceptible, or resistant to a particular antimicrobial agent on the basis of the diameters of the inhibitory zones that matched the criteria of the manufacturer's interpretation Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were assessed using the broth microdilution method 11 . An inoculum of the microorganism was prepared from 24 h cultures grown in Mueller-Hinton broth (MHB) (HiMedia) and suspension was adjusted with a turbidity equivalent to that of a 0. 
Haemolysis test
Haemolysis test was employed to determine cellular toxicity of the extract as previously described
12
. Plant extracts at concentrations ranging from 6 to 32 mg/ml, were incubated with an equal volume of 1% human red blood cells in phosphate buffered saline (10mM PBS, pH 7.4) at 37°C for 1 h. Non-hemolytic and 100% hemolytic controls were the buffer alone and the buffer containing 1% Triton X-100, respectively. Cell lysis was monitored by measuring the release of hemoglobin spectrophotometrically at 540 nm.
Phytochemical screening
Phytochemical screening was performed following the method described previously 13 . For total phenolics, 0.2 ml of plant extract (5 mg/ml) was diluted to 3 ml with water and 0.5 ml of Folin-Ciocalteu reagent was added. Following incubation for 3 min at room temperature, 2 ml of 20% w/v Na 2 CO 3 was added. The mixture was heated in a boiling water bath for 1 min and allowed to cool to room temperature. It was centrifuged and the content of phenolics in the supernatant was determined spectrophotometrically at 650 nm (model U-2000, Hitachi), and expressed as mg/g of gallic acid equivalents (GAE) per lyophylisate.
For total flavonoids, 0.2 ml of dried extract (5 mg/ml) was diluted to 2 ml with methanol, and 0.1 ml of 10% w/v aluminium chloride, 0.1 ml of 1 mol/lit potassium acetate and 2.8ml of water were added sequentially. The mixture was then incubated at room temperature for 30 min. Following centrifugation, the flavonoids content of the supernatant was measured spectrophotometrically at 415 nm, and expressed as mg/g, based on rutin as standard.
RESULTS
The results of the tests are presented in Tables 2 -4 . The antibiotic susceptibility test of the clinical and environmental strains included here was performed to confirm their multi-drug resistance patterns. These were found to conform to multi-drug resistant. Antibiotic resistance patterns of V. cholerae, strains PC4, PC65, SG24 and NB2 were Fz-A, A-T, Co-S, and T-Na-Fz-Co-S, respectively.
The extracts of T. chebula and S. cumini had strong bactericidal activity with MIC ranging from 0.125 to 3 mg/ml and MBC ranging from 0.25 to 4 mg/ml, against V. cholerae (serotypes O1, O139, and non-O1, non-O139) A. hydrophila, and B. subtilis; and moderate activity with MIC, 8-12 mg/ml and MBC ranging from 16.0 to 24.0 mg/ml against P. aeruginosa, ETEC and EHEC. S. nigrum was active against V. cholerae and did not show activity against E. coli and P. aeruginosa. The MBC of P. kurrooa extract was between 3 and 32 mg/ml against V. cholerae and A. hydrophila, but the extract was inactive against E. coli and P. aeruginosa. The flower extract of B. monosperma showed bactericidal activity against V. cholerae, A. hydrophila and B. subtilis with MBC ranging from 1.75 to 8 mg/ml. W. somnifera showed strong bactericidal activity (MBC, 2 mg/ml) against B. subtilis and moderate activity against V. cholerae and A. hydrophila with MBC ranging from 16 to 32 mg/ml. S. indica evoked strong bactericidal activity against V. cholerae and A. hydrophila with MBC ranging from 1 to 5 mg/ml while A. lebbeck and A. marmelos had moderate activity against V. cholerae, A. hydrophila and B. subtilis. In addition, the bactericidal activity of S. indica against E. coli and P. aeruginosa was not observed within the concentration ranges of the extracts tested. Except for S. cumini (MIC, 24 mg/ml and MBC, 32 mg/ml), all extracts were inactive against K. pneumoniae.
Phytochemical screening revealed that the crude methanol extracts contained phenolics (10.6±0.9 -365.9±16.1 mg/g) and flavonoids (0 -65.6±2.8 mg/g) (see Table 2 ). None of the extracts tested in the present study released haemoglobin and hence were not 
DISCUSSION
The extracts of the medicinal plants tested were effective antibacterial agents against a group of microorganisms that are implicated in either cholera, diarrheoa, dysentery or other gastrointestinal disorders. All of these plants had bactericidal activity against at least one of the test microorganisms with MIC ranging between 0.125 and 32 mg/ml and MBC between 0.25 and 32 mg/ml. Among these, T. chebula and S. cumini showed the most promising broad spectrum antibacterial properties, inhibiting all of the strains tested, especially V. cholerae, A. hydrophila and B. subtilis, with MBC ranging between 0.25 and 4 mg/ml. Additionally, the extracts of B. monosperma, P. kurrooa, S. indica and S. nigrum showed strong bactericidal activity against V. cholerae. W. somnifera, B. monosperma, A. marmelos and S. indica, and were also active against the Gram-positive bacterium, B. subtilis. T. chebula showed bactericidal activity against the strain of EHEC, the causative agent of hemorrhagic colitis, dysentery and haemolytic uraemic syndrome (HUS).
It is interesting to note that the extracts of the plants used to treat cholera or diarrheoa in traditional Medicare systems [2] [3] [4] [5] [6] [7] were effective against the strains of V. cholerae, the causative agents of the dreadful disease, cholera, and cholera-like diseases. To the best of our knowledge, the plant extracts used in this study are being shown for the first time to demonstrate bactericidal activity against enterotoxigenic Escherichia coli (ETEC), enterohaemorrhagic E. coli (EHEC), A. hydrophila, and multi-serogroup strains of V. cholerae, the causative agents of different 
CONCLUSION
The results of this study give some scientific credence to the indigenous uses of the Indian medicinal plants evaluated for the treatment of gastrointestinal disorders such as cholera and diarrheal diseases.
